| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1612863A Deuterated substituted pyrazolylbenzylsulfonamides pharmaceutical compositions containing them and use thereof |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612739A Method for treating or preventing inflammatory diseases |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1611253A Medicine for treating lumbosacral pain and its preparing method |
| 05/04/2005 | CN1611248A Chinese medicine composition for treating rheumatoid disease |
| 05/04/2005 | CN1611240A Fresh ginger soft capsule and its preparing method |
| 05/04/2005 | CN1611237A Musk tendon relaxation and joint rigidity relieving medicine |
| 05/04/2005 | CN1611213A Novel 13 uses of neoarsphenamine |
| 05/04/2005 | CN1200000C Cyclie somatostatin analogs |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199950C Quinolene derivatives as anti-inflammation agents |
| 05/04/2005 | CN1199669C Medicine for curing cervicitis and preparing method thereof |
| 05/04/2005 | CN1199658C Chinese medicine navel melted tablet for treating menalgia and its prepn |
| 05/04/2005 | CN1199636C Use of 15-deoxysperguallin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6888001 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function. |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887994 C-nitroso compounds and use thereof |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887883 Combating angiogenic activity in a human comprising administering to a chrysanthone compound |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | CA2320388C Novel dihydroxyhexanoic acid derivatives |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 05/03/2005 | CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 04/28/2005 | WO2005037814A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2005 | WO2005037783A2 Use of tricyclic compounds as glycine transport inhibitors |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2) |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090538 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090525 carboxymethylated N-(nitrogen group functionalized alkyl- carbonylhydrazido)- or carbonylaminomethylcarbonyl)- substituted; integrin inhibitors used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050090516 Novel substituted imides |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090493 Useful as anti-cancer agents; exhibit apoptotic effect in a warm-blooded animal such as man; for example, 2-{4-[3-(N,N-Dimethyl)amino-2-hydroxy-propoxy]anilino}-4-(2,4-difluoro-(N-cyanomethyl)anilino)pyrimidine |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050090467 administering 4-thiouridine, isomaltitol and uridine as antiinflammatory agents and/or problems in hemostasis related to platelet function |
| 04/28/2005 | US20050090436 Human tumor necrosis factor receptors TR21 and TR22 |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089545 Drug delivery system for the subconjunctival administration of fine grains |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089499 Forming a fermentation broth from plants inoculation with microorganisms and fermenttion to produce active component for use on skin and hair |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | US20050087198 Method for systemic drug delivery through the nail |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542761A1 Analgesia method |
| 04/28/2005 | CA2542504A1 Lipids containing omega-3 and omega-6 fatty acids |
| 04/28/2005 | CA2542440A1 Furan derivatives as ep4 receptor antagonists |
| 04/28/2005 | CA2542395A1 Treatment of arthritic conditions, chronic inflammation or pain |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/28/2005 | CA2541265A1 Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
| 04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1525030A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1455799B1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1357910B1 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | EP1325010B1 Substituted 3.4-dihydro-pyrimido [1,2-a]pyrimidines and 3.4-dihydropyrazino [1,2-a]pyrimidines |